452 reports of this reaction
3.2% of all PRASUGREL HYDROCHLORIDE reports
#4 most reported adverse reaction
HAEMORRHAGE is the #4 most commonly reported adverse reaction for PRASUGREL HYDROCHLORIDE, manufactured by Cosette Pharmaceuticals, Inc.. There are 452 FDA adverse event reports linking PRASUGREL HYDROCHLORIDE to HAEMORRHAGE. This represents approximately 3.2% of all 14,129 adverse event reports for this drug.
Patients taking PRASUGREL HYDROCHLORIDE who experience haemorrhage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAEMORRHAGE is moderately reported among PRASUGREL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to haemorrhage, the following adverse reactions have been reported for PRASUGREL HYDROCHLORIDE:
The following drugs have also been linked to haemorrhage in FDA adverse event reports:
HAEMORRHAGE has been reported as an adverse event in 452 FDA reports for PRASUGREL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAEMORRHAGE accounts for approximately 3.2% of all adverse event reports for PRASUGREL HYDROCHLORIDE, making it a notable side effect.
If you experience haemorrhage while taking PRASUGREL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.